| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.55B | 2.40B | 2.24B | 2.30B | 2.15B |
| Gross Profit | 91.20M | 2.40B | 2.24B | 161.40M | 194.00M |
| EBITDA | 178.40M | 154.50M | 168.70M | 242.00M | 276.00M |
| Net Income | 70.90M | 53.60M | 40.80M | 119.40M | 146.20M |
Balance Sheet | |||||
| Total Assets | 2.35B | 2.25B | 2.16B | 2.32B | 2.25B |
| Cash, Cash Equivalents and Short-Term Investments | 531.60M | 536.50M | 506.80M | 669.10M | 689.70M |
| Total Debt | 619.30M | 593.30M | 603.70M | 639.30M | 634.00M |
| Total Liabilities | 1.55B | 1.47B | 1.41B | 1.52B | 1.49B |
| Stockholders Equity | 766.40M | 746.80M | 717.90M | 768.10M | 724.20M |
Cash Flow | |||||
| Free Cash Flow | 152.70M | 146.90M | 1.40M | 148.30M | 290.30M |
| Operating Cash Flow | 180.50M | 158.60M | 18.80M | 175.10M | 314.80M |
| Investing Cash Flow | -54.30M | -20.70M | -21.60M | -41.80M | -73.30M |
| Financing Cash Flow | -102.70M | -112.50M | -136.20M | -174.50M | -70.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £1.44B | 4.93 | 12.27% | 5.71% | 4.80% | 37.75% | |
69 Neutral | £129.38M | 13.93 | 8.96% | 2.05% | 10.84% | 113.75% | |
67 Neutral | £1.18B | 2.45 | 10.25% | 3.62% | -8.66% | 553.35% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | £225.37M | 7.67 | 20.71% | 3.59% | 20.46% | ― | |
54 Neutral | £1.14B | 19.15 | 9.70% | 2.20% | 7.81% | 22.76% | |
50 Neutral | £218.47M | 35.14 | 5.91% | 2.71% | -14.09% | ― |